Aplagon

Pioneering first-in-class treatments for thromboinflammatory diseases

Aplagon was founded in 2009, is headquartered in Helsinki, Finland, and has $9.9M in recorded funding across 2 rounds.

Headquarters
Helsinki
Founded
2009
Business Model
B2B
Total Funding
$9.9M
Last Round
$7.3M Venture RoundFeb 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases. It is based on pioneering research on mast cell-derived heparin proteoglycans (HEP-PG) by Prof. Riitta Lassila's group at the Wihuri Research Institute in Helsinki, Finland, which led to Aplagon's lead candidate APAC — a heparin proteoglycan mimetic now in clinical studies across two lead cardiovascular indications. Aplagon's offices and laboratory are at Biomedicum Helsinki, a prominent life-science hub in Finland.

Summary

Aplagon is a Biotech company based in Helsinki, Finland, founded in 2009. It has raised $9.9M in total across 2 rounds, most recently a $7.3M Venture Round in Feb 2025. Investors include Fåhraeus Startup and Growth, European Innovation Council Fund and Innovestor.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundFeb 2025
$7.3M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aplagon on Indexed.vc
<a href="https://indexed.vc/companies/aplagon"><img src="https://indexed.vc/api/badge/company/aplagon" alt="Aplagon on Indexed.vc" width="260" height="76" /></a>